Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers shows continued positive order momentum, confirms outlook
Press release

Siemens Healthineers shows continued positive order momentum, confirms outlook

Siemens Healthineers AG today announces its results for the third quarter of fiscal year 2024 ended June 30, 2024.
Published on July 31, 2024

Q3 Fiscal Year 2024 

  • Good equipment book-to-bill ratio of 1.07 further increases already high order backlog 
  • Comparable revenue growth of 4.3% against a very strong prior-year quarter (10.1% excluding rapid COVID-19 antigen tests) and despite continued order delays in China 
  • Imaging comparable revenue growth of 3.8% against sharp growth in the prior-year quarter; adjusted EBIT margin of 20.0% 
  • Diagnostics comparable revenue growth of 2.1%; adjusted EBIT margin of 7.4% clearly above the prior-year quarter 
  • Varian comparable revenue growth of 9.6%; adjusted EBIT margin of 16.6% shows clear improvement over prior-year quarter 
  • Advanced Therapies comparable revenue growth of 0.4% against significant growth in the prior-year quarter; adjusted EBIT margin of 13.9% 
  • Overall adjusted EBIT margin of 15.2% 
  • Adjusted basic earnings per share of €0.52

Outlook for Fiscal Year 2024 

We confirm our expectation of comparable revenue growth of between 4.5% and 6.5% (between 5.0% and 7.0% excluding revenue from rapid COVID-19 antigen tests) and adjusted basic earnings per share of between €2.10 and €2.30. 

Bernd Montag, CEO of Siemens Healthineers AG: 

»We made good progress again in the third quarter, despite ongoing order delays in China. Varian and Diagnostics especially contributed to the strong operating performance. We confirm our outlook for the financial year.«

Download Quarterly Statement(pdf, 280.23 KB)

Siemens Healthineers 2024

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at www.siemens-healthineers.com.